Anticipated year over year growth of the treatment population (number of member lives) eligible for chronic weight management with GLP-1 23
Other adverse events with an incidence 5% are as follows: abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis
This stimulates the production and release of endogenous growth hormone while preserving the bodys natural pulsatile secretion pattern
doi: 10.1152/ajpregu.00588.2012 [DOI] [PMC free article] [PubMed] [Google Scholar] 14
One of the key aspects of Ipamorelins mechanism of action is its ability to mimic ghrelin, a hormone that binds to ghrelin receptors in the brain
doi:10.1111/j.1432-1033.1994.1151b.x 30